The provided abstract contains only funding and disclosure information for a study evaluating trajectories of adherence to extended treatment with direct oral anticoagulants.
Observational
This research was supported by the BMS/Pfizer Alliance American Thrombosis Investigator Initiated Research Program. The funding source had no role in the design, collection, analysis, or interpretation of the data or the decision to submit the article for publication. Dr Lo-Ciganic reported receiving research funding from Merck Sharp & Dohme Corp. Dr Dietrich reported receiving honorarium for training and education from BMS/Pfizer. Dr DeRemer is a stockholder of Portola Pharmaceuticals and reported receiving personal fees for advisory board meeting from BMS. No other disclosures were reported.
Kang et al. (Fri,) conducted a observational in Venous thromboembolism. Direct oral anticoagulants was evaluated on Recurrent venous thromboembolism and major bleeding. The provided abstract contains only funding and disclosure information for a study evaluating trajectories of adherence to extended treatment with direct oral anticoagulants.